In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...

Jack Cowin is the burger billionaire who sells millions of beef patties to happy Hungry Jack’s customers. But, trying to ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Edward Jones has upgraded CVS Health (CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. Read more here.

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Express Scripts aims to ensure that patients directly benefit from its negotiations with drug manufacturers. The new approach will protect patients from paying inflated list prices for medications, ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high ...

Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...